Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 38.24 USD -3.26% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Veracyte Inc?
Write Note

Veracyte Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Veracyte Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Veracyte Inc
NASDAQ:VCYT
Cash from Financing Activities
$10.1m
CAGR 3-Years
-74%
CAGR 5-Years
-40%
CAGR 10-Years
-16%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Veracyte Inc's Cash from Financing Activities?
Cash from Financing Activities
10.1m USD

Based on the financial report for Sep 30, 2024, Veracyte Inc's Cash from Financing Activities amounts to 10.1m USD.

What is Veracyte Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-16%

Over the last year, the Cash from Financing Activities growth was 341%. The average annual Cash from Financing Activities growth rates for Veracyte Inc have been -74% over the past three years , -40% over the past five years , and -16% over the past ten years .

Back to Top